Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Apr 2026 for Kailera Therapeutics, Inc..
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew T. Kaplan: trading record in brief
Andrew T. Kaplan discloses dealings in 2 companies, chiefly Kailera Therapeutics, Inc. and Surgery Partners, Inc. In total, 4 filings cover trades dated from 19 December 2023 to 20 April 2026.
On the open market, the record shows 1 purchase worth €114.0M and 1 sale worth €239.6M. Taken together, the sales exceed the purchases by €125.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 1 purchase and no sales on the market.
The latest filing, published on 20 April 2026, reports a transaction in Kailera Therapeutics, Inc. The clock since the last published purchase (20 April 2026) now reads 187 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew T. Kaplan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
17,857,143 sharesCommon StockSEC:0001193125-26-164388:0
8,398,438 shares@ US$16.00100.0% of flowCommon StockSEC:0001193125-26-164388:1
Canonical exit: 19 Jul 2026 (T+90)
474,407 shares0Common StockSEC:0000950170-23-072382:1
7,826,870 shares@ US$33.44100.0% of flowCommon StockSEC:0000950170-23-072382:0
4 of 2 declarations
